NEW YORK, December 3, 2024 — Three subsidiaries of Danaher Corporation (“Danaher”), a leading global life sciences and diagnostics innovator, are supporting the nonprofit Human Immunome Project (HIP) with access to reagents, assays, and equipment. Danaher’s participation will help HIP to generate the world’s most comprehensive immunological dataset and provide a transformative new resource to the…

Read More